| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 04/06/2000 | WO1999061583A3 Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction |
| 04/06/2000 | WO1999059608A3 Osteoporosis treatment |
| 04/06/2000 | WO1999051625A3 Peptides causing formation of compact structures |
| 04/06/2000 | WO1999036568A3 Method for identifying t-cell stimulating protein fragments |
| 04/06/2000 | CA2347923A1 Solid phase synthesis with the solid phase consisting of two different substrates |
| 04/06/2000 | CA2345407A1 Synthesis of cyclic peptides |
| 04/06/2000 | CA2345332A1 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 04/06/2000 | CA2345067A1 Auxiliary for amide bond formation |
| 04/06/2000 | CA2341763A1 Antigenic peptides of aglyco 10b and antibodies thereto |
| 04/05/2000 | EP0990156A1 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 04/05/2000 | EP0990147A1 Acrylic microchannels and their use in electrophoretic applications |
| 04/05/2000 | EP0794959B1 Amino acids for making betides and methods of screening and making betide libraries |
| 04/05/2000 | EP0750631B1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 04/05/2000 | EP0741869B1 Specific binding substances for antibodies and their use for immunoassays or vaccines |
| 04/05/2000 | EP0618811B1 Proteolytic mixture containing escharase and method of isolating same |
| 04/05/2000 | EP0568622B1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 04/04/2000 | US6046306 PNA synthesis using an amino protecting group which is labile to weak acids |
| 04/04/2000 | US6046305 Heterofunctionalized star-shaped poly(ethylene gycols) for protein modification |
| 04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
| 04/04/2000 | US6046053 Method for amino acid sequencing of protein or peptide from carboxy terminus thereof |
| 04/04/2000 | US6046024 Method of producing a fibrin monomer using a biotinylated enzyme and immobilized avidin |
| 04/04/2000 | US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/04/2000 | CA2173878C Polynucleotide for treating systemic lupus erythematosus |
| 04/04/2000 | CA1340948C Peptidylaminodiols |
| 04/04/2000 | CA1340942C Processes for the treatment of vascular disease |
| 04/04/2000 | CA1340940C Peptidylaminodiols |
| 03/30/2000 | WO2000017631A1 Method for separation of macromolecules |
| 03/30/2000 | WO2000017328A2 Fibrils |
| 03/30/2000 | WO2000017182A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 03/30/2000 | WO2000016897A1 Microfiltration filter layer for separating endotoxins and the use of said microfiltration filter layer |
| 03/30/2000 | WO2000016803A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 03/30/2000 | CA2343645A1 Process for obtaining hmg-coa reductase inhibitors of high purity |
| 03/30/2000 | CA2342783A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 03/29/2000 | EP0988314A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/29/2000 | EP0988063A2 Process for reducing the concentration of viral and molecular pathogens in a biological material |
| 03/29/2000 | EP0697891B1 Polyoxime compounds and their preparation |
| 03/29/2000 | EP0675873A4 Synthesis of encoded polymers |
| 03/28/2000 | US6043347 Compositions and methods for treating viral infections |
| 03/28/2000 | US6043222 Two new human DnaJ-like proteins |
| 03/28/2000 | US6043215 Preparation of factor IX |
| 03/28/2000 | US6043025 Kit containing matched set of luminescent dyes capable of covalently binding to protein; dyes migrate the same but have different emission wavelengths; for simple, fast and accurate method of comparing/contrasting protein content of samples |
| 03/28/2000 | US6042824 Combining the substrate and a crosslinked enzyme crystal formulation containing a crosslinked enzyme and a surfactant which acts upon the substrate in presence of organic solvent or aqueous-organic solvent to form a product |
| 03/28/2000 | US6042822 Mixture of alpha-interferon-conjugate positional isomers comprises an alpha-interferon covalently conjugated to a non-antigenic alkyl terminated polyalkylene oxide at a histidine residue on alpha interferon |
| 03/28/2000 | CA2004885C Anticoagulant peptides |
| 03/23/2000 | WO2000015777A1 Gene and protein libraries and methods relating thereto |
| 03/23/2000 | WO2000015760A1 Streptococcal c beta protein compositions |
| 03/23/2000 | WO2000015658A1 FACTOR VIIa INHIBITORS |
| 03/23/2000 | WO2000015655A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
| 03/23/2000 | WO2000015653A2 Apparatus for, and method of, storing a plurality of chemical compounds |
| 03/23/2000 | WO2000015605A2 Chiral cyanoamines and methods of preparation |
| 03/23/2000 | WO1999065931A9 Non-enzymatic chemical amidation process |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | CA2344048A1 Factor viia inhibitors |
| 03/23/2000 | CA2343051A1 Streptococcal c beta protein compositions |
| 03/23/2000 | CA2342395A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
| 03/22/2000 | EP0987275A2 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/22/2000 | EP0987274A1 Factor VIIa Inhibitors |
| 03/22/2000 | EP0986754A1 Synthetic antibiotics |
| 03/22/2000 | EP0986644A1 Production of erythropoietin by endogenous gene activation |
| 03/22/2000 | EP0986585A1 Use of ylides of phosphorus as slightly nuceophilic strong bases |
| 03/22/2000 | EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals |
| 03/22/2000 | CN1247871A Antifungal albumen |
| 03/21/2000 | US6040423 Solid phase synthesis using one-piece support to synthesize a plurality of different peptides by spotting n-protected amino acid solution in discrete zones, coupling c-terminal to support, then coupling additional amino acids |
| 03/21/2000 | US6040422 Reacting a fluoroformamidinium salt with an n-amino protected, optionally side chain protected amino acid; then reacting product with a carboxy protected amino acid; for compounds with long term storage stability |
| 03/21/2000 | US6040193 Combinatorial strategies for polymer synthesis |
| 03/21/2000 | US6039945 Administering purified prothrombinase factor to humans |
| 03/21/2000 | CA2166397C Method and apparatus for designing molecules with desired properties by evolving successive populations |
| 03/16/2000 | WO2000014242A1 Novel protein, gene encoding the same and utilization thereof |
| 03/16/2000 | WO2000014113A2 Method of stimulating prosaposin receptor activity |
| 03/16/2000 | WO2000014107A1 Temperature dependent protein purification |
| 03/16/2000 | WO1999062939A3 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/16/2000 | DE19821812C2 Miniaturisierte Trennsäule Miniaturized separation column |
| 03/16/2000 | CA2341498A1 Temperature dependent protein purification |
| 03/16/2000 | CA2341325A1 Method of stimulating prosaposin receptor activity |
| 03/15/2000 | EP0736040B1 Use of igf-bp for refolding of igf |
| 03/15/2000 | EP0648279B1 Acceptor for fucosyltransferase |
| 03/15/2000 | EP0541726B1 Growth factor compositions, preparation and use |
| 03/15/2000 | CN2368847Y Crystallizer for aerospace growth of protein crystal |
| 03/14/2000 | US6037363 Respiratory system disorders, cystic fibrosis |
| 03/14/2000 | US6037320 Neurotrophic factor (NT-4) |
| 03/14/2000 | US6036920 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization |
| 03/14/2000 | US6036861 Fluidized bed system comprising surface modified zirconium oxide particles of capacity factor greater than 10; particles have a core zirconium oxide particle of given size and specific gravity; stable at high linear fluid velocities |
| 03/14/2000 | CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/14/2000 | CA2010177C Purified mite allergen |
| 03/14/2000 | CA1340926C Human rhinovirus peptides |
| 03/09/2000 | WO2000013026A1 Energy transfer dyes |
| 03/09/2000 | WO2000013019A1 Receptor for underivatized, aqueous soluble beta-(1,3)-glucan |
| 03/09/2000 | WO2000013018A2 Support for a method for determining analytes and a method for producing the support |
| 03/09/2000 | WO2000013017A2 Method and device for producing and/or analyzing biochemical reaction supporting materials |
| 03/09/2000 | WO2000012587A2 Polyamide chains of precise length, methods to manufacture them and their conjugates |
| 03/09/2000 | WO2000012575A1 Method for producing polymeric solid phase supporting materials |
| 03/09/2000 | WO2000012556A1 High-affinity antibodies |
| 03/09/2000 | WO2000012554A1 Method for marked chemokine synthesis, marked chemokine and analysis kit |
| 03/09/2000 | WO2000012542A2 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties |
| 03/09/2000 | WO2000012541A2 Cytotoxic peptides modified by bulky or lipophilic moieties |
| 03/09/2000 | WO2000012537A1 Process for the preparation of active somatotropin from inclusion bodies |
| 03/09/2000 | WO2000012536A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/09/2000 | WO2000012524A1 Purification of oligomers using dual-end selection |
| 03/09/2000 | WO2000012506A2 Collections of compounds |
| 03/09/2000 | WO2000012140A1 Method for labeling biopolymers using isotopes |